Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

Bibliographic Details
Main Authors:	Jorge R. Georgakopoulos, MD, Tina Felfeli, MD, Aaron M. Drucker, MD, ScM, FRCPC, Christine E. Jo, BSc, Vincent Piguet, MD, PhD, FRCP, Jensen Yeung, MD, FRCPC
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	JAAD International
Subjects:	adverse event atopic dermatitis drug survival dupilumab efficacy safety
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328721000390

Internet